Futura Medical Developments Ltd.
🇬🇧United Kingdom
Clinical Trials
13
Active:7
Completed:6
Trial Phases
3 Phases
Phase 1:10
Phase 2:1
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
Phase 1
10 (76.9%)Phase 3
2 (15.4%)Phase 2
1 (7.7%)Clinical Investigation Using MED3000 Gel or Tadalafil Tablets in the Treatment of Erectile Dysfunction
Phase 3
Completed
- Conditions
- Erectile Dysfunction
- Interventions
- Device: MED3000 (Male)Device: MED3000 (Female)
- First Posted Date
- 2021-08-02
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Futura Medical Developments Ltd.
- Target Recruit Count
- 116
- Registration Number
- NCT04984993
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇧🇬Medical Center "Asklepii"OOD, Dupnitsa, Bulgaria
🇧🇬ЕТ "Аssoc. Prof. Stefan Popov - Individual Practice for Specialized Outhospital medical care for Neurology and Pscyhiatry", Plovdiv, Bulgaria
Study to Determine the Effect of a Newly Formulated Tetracaine Product PET500 on Penile Skin Sensation
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2020-01-30
- Last Posted Date
- 2020-01-30
- Lead Sponsor
- Futura Medical Developments Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT04247230
Evaluating MED2005 & Nitrostat Bioavailability
Phase 1
Completed
- Conditions
- Erectile Dysfunction
- Interventions
- First Posted Date
- 2019-07-05
- Last Posted Date
- 2019-07-05
- Lead Sponsor
- Futura Medical Developments Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT04008732
- Locations
- 🇬🇧
Simbec Research Limited, Merthyr Tydfil, Wales, United Kingdom
Clinical Trial Using Topically Applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction
Phase 3
Completed
- Conditions
- Erectile Dysfunction
- Interventions
- Drug: MED2005
- First Posted Date
- 2019-01-23
- Last Posted Date
- 2022-03-02
- Lead Sponsor
- Futura Medical Developments Ltd.
- Target Recruit Count
- 1005
- Registration Number
- NCT03813992
- Locations
- 🇧🇬
UMHAT Burgas EAD, Burgas, Bulgaria
🇧🇬Multiprofile Hospital for Active Treatment, Pleven, Bulgaria
🇧🇬University Multiprofile Hospital for Active Treatment, Plovdiv, Bulgaria
Assess the Efficacy and Safety in Volunteers of DCF100, TIB200 and SPR300 vs. Placebo and Control(s) in a UV Pain Model
Phase 1
Completed
- Conditions
- Pain
- Interventions
- First Posted Date
- 2016-01-28
- Last Posted Date
- 2021-01-27
- Lead Sponsor
- Futura Medical Developments Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT02666846
- Locations
- 🇬🇧
PAREXEL EPCU Northwick Park, Harrow, Middlesex, United Kingdom
- Prev
- 1
- 2
- Next
News
No news found